DK630589D0 - 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION - Google Patents
2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITIONInfo
- Publication number
- DK630589D0 DK630589D0 DK630589A DK630589A DK630589D0 DK 630589 D0 DK630589 D0 DK 630589D0 DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 D0 DK630589 D0 DK 630589D0
- Authority
- DK
- Denmark
- Prior art keywords
- dideoxypurinnucleosid
- purine nucleoside
- inhibitor composition
- nucleoside phosphorylase
- phosphorylase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28415388A | 1988-12-14 | 1988-12-14 | |
US31535489A | 1989-02-24 | 1989-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK630589D0 true DK630589D0 (en) | 1989-12-13 |
DK630589A DK630589A (en) | 1990-06-15 |
Family
ID=26962435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK630589A DK630589A (en) | 1988-12-14 | 1989-12-13 | 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0374096B1 (en) |
JP (1) | JPH02204414A (en) |
KR (1) | KR900009083A (en) |
AU (1) | AU628113B2 (en) |
CA (1) | CA2005205A1 (en) |
DE (1) | DE58902899D1 (en) |
DK (1) | DK630589A (en) |
IE (1) | IE893991L (en) |
IL (1) | IL92587A (en) |
NZ (1) | NZ231718A (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ229453A (en) * | 1988-06-10 | 1991-08-27 | Univ Minnesota & Southern Rese | A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents |
ES2106732T3 (en) * | 1989-02-27 | 1997-11-16 | Biocryst Pharm Inc | DESAZAGUANINAS SUBSTITUTED IN 9 AND NOT SUBSTITUTED IN 8. |
JP2619710B2 (en) * | 1989-02-27 | 1997-06-11 | 日本製紙 株式会社 | Method for producing 2 ', 3'-dideoxypurine nucleosides |
DK0465297T3 (en) * | 1990-07-04 | 1996-02-19 | Merrell Pharma Inc | 9-Purinylphosphonsyre derivatives |
SK279262B6 (en) * | 1991-05-16 | 1998-08-05 | Glaxo Group Limited | Antiviral combination, pharmaceutical composition containing thereof and its use |
US5494912A (en) * | 1991-06-26 | 1996-02-27 | Merrell Pharmaceuticals Inc. | 9-purinyl phosphonic acid derivitives for treating gout |
CZ27399A3 (en) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments |
PE20050347A1 (en) * | 2003-08-26 | 2005-05-04 | Teijin Pharma Ltd | PYRROLOPYRIMIDINE DERIVATIVES |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
DE102006017600A1 (en) * | 2006-02-09 | 2007-08-16 | Friedel, Ruthard, Dr. | Use of nucleoside analogues such as purine derivatives, as medicines against viruses and cytostatic against cancer, where the nucleoside analogue has a donor group, acceptor group, and pairs only with natural base thymine |
US9452217B2 (en) * | 2013-06-22 | 2016-09-27 | Nitor Therapeutics | Methods for potentiating immune response for the treatment of infectious diseases and cancer |
US10729711B2 (en) | 2016-08-30 | 2020-08-04 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods for treatment using small molecule potassium-sparing diuretics and natriuretics |
GB201820098D0 (en) * | 2018-12-10 | 2019-01-23 | Cambridge Entpr Ltd | Methods of cancer treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60126220A (en) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | Nucleic acid component composition |
JPS62501712A (en) * | 1985-08-26 | 1987-07-09 | アメリカ合衆国 | Anti-HTLV-3/LAV agent containing 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine |
-
1989
- 1989-12-05 DE DE8989810920T patent/DE58902899D1/en not_active Expired - Fee Related
- 1989-12-05 EP EP89810920A patent/EP0374096B1/en not_active Expired - Lifetime
- 1989-12-07 IL IL9258789A patent/IL92587A/en unknown
- 1989-12-08 AU AU46074/89A patent/AU628113B2/en not_active Ceased
- 1989-12-12 KR KR1019890018345A patent/KR900009083A/en not_active Application Discontinuation
- 1989-12-12 NZ NZ231718A patent/NZ231718A/en unknown
- 1989-12-12 CA CA002005205A patent/CA2005205A1/en not_active Abandoned
- 1989-12-13 JP JP1321624A patent/JPH02204414A/en active Pending
- 1989-12-13 DK DK630589A patent/DK630589A/en not_active Application Discontinuation
- 1989-12-13 IE IE893991A patent/IE893991L/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL92587A (en) | 1994-04-12 |
KR900009083A (en) | 1990-07-02 |
EP0374096B1 (en) | 1992-12-02 |
DE58902899D1 (en) | 1993-01-14 |
IE893991L (en) | 1990-06-14 |
EP0374096A1 (en) | 1990-06-20 |
AU4607489A (en) | 1990-06-21 |
AU628113B2 (en) | 1992-09-10 |
DK630589A (en) | 1990-06-15 |
JPH02204414A (en) | 1990-08-14 |
NZ231718A (en) | 1992-02-25 |
IL92587A0 (en) | 1990-08-31 |
CA2005205A1 (en) | 1990-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT526253E (en) | ANALOGS OF NUCLEOSIDE 1,3-OXATIOLANE | |
LV5781A4 (en) | Healing Nucleoside | |
DK23489A (en) | nucleoside | |
KR900007991A (en) | Primer composition | |
DK375989A (en) | purine derivatives | |
DK630589D0 (en) | 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION | |
DK564088D0 (en) | nucleoside | |
NO921679L (en) | PURIN NUCLEOSIDE PHOSPHORYLASE INHIBITORS | |
NZ235534A (en) | 3'-azido-2',3'-dideoxy purine derivatives | |
FI932868A (en) | 2'-DEOXY-2'2'-DIFLUOR (2,6,8-SUBSTITUTES) PURINNUKLEOSIDER MED VIRUS-OCH CANCERHAEMMANDE ACTIVITIES, AS WELL | |
EP0365849A3 (en) | Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives | |
OA09697A (en) | Nucleoside derivatives | |
DE68914750D1 (en) | Therapeutic nucleosides. | |
DK626989A (en) | adenosine | |
DK95791A (en) | nucleoside analogues | |
LTIP1982A (en) | 9-deazahypoxantines, useful as purine nucleoside phosphorylase inhibitors | |
NO891835L (en) | PRODRUG FORMS OF 2 ', 3'-DIDEHYDRO-2', 3'-DIDEOXY NUCLEOSIDES. | |
DK339189D0 (en) | purine derivatives | |
DE69002365T2 (en) | Antiviral composition. | |
ZA899510B (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition | |
ATE104675T1 (en) | THERAPEUTIC NUCLEOSIDES. | |
NO921776L (en) | Nucleoside derivative | |
IE891764L (en) | Nucleoside compositions | |
GB8925039D0 (en) | Nucleoside derivatives | |
GB8925037D0 (en) | Nucleoside derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |